Tumour necrosis factor inhibitors in Crohn's disease and the effect on surgery rates

Eberhardson, M., Myrelid, P., Söderling, J. K., Ekbom, A., Everhov, Å. H., Hedin, C. R. H., Neovius, M., Ludvigsson, J. F., & Olén, O. (2022). Tumour necrosis factor inhibitors in Crohn’s disease and the effect on surgery rates. Colorectal Disease, 24(4), 470–483. Portico. https://doi.org/10.1111/codi.16021
Authors:
Michael Eberhardson
Pär Myrelid
Jonas K. Söderling
Anders Ekbom
Åsa H. Everhov
Charlotte R. H. Hedin
Martin Neovius
Jonas F. Ludvigsson
Ola Olén
Hans Strid
Henrik Hjortswang
Malin Olsson
Jan Björk
Jonas L. Bengtsson
Jonas Halfvarson
Marie A. Andersson
Pontus Karling
Martin Rejler
Susanna Jäghult
Ulrika L. Fagerberg
Olof Grip
Caroline Nordenvall
Affiliated Authors:
Jonas F. Ludvigsson
Columbia Affiliation:
Subjects:
Crohn Disease (MeSH)
Author Keywords:
crohn's disease
biologics
bowel surgery
elink
Publication Type:
Article
Unique ID:
10.1111/codi.16021
PMID:
34905282
DOI:
10.1111/codi.16021
Journal:
Colorectal Disease
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: